Methylation-based markers researches for esophageal cancer have mainly been focused on hypermethylation in promoter region CpG island of numerous tumor suppressor genes, such as APC and CDKN2A, which thus were thought to be potential biomarkers for the diagnosis of BE and esophageal cancer [14, 15]. This evidence concerns the gene CDKN2A and esophageal cancer.